Defendant Name:
Elanco Animal Health Inc.
Defendant Type:
Public Company
Document Reference:
34-104911
Document Details
Legal Case Name
In the Matter of Elanco Animal Health Inc.
Document Name
Order Appointing Fund Administrator, Setting Administrator's Bond Amount, and Authorizing the Approval and Payment of the Fees and Expenses of Administration
Document Date
02-Mar-2026
Document Format
Administrative Proceeding
Allegation Type
Issuer Reporting and Disclosure
Document Summary
The Commission ordered that: "A. Epiq is appointed as the Fund Administrator . . .
B. Epiq shall obtain a bond . . . in the amount of $15,000,000.00;
C. the Fund Administrator will submit invoices to the Commission staff for services rendered . . . and
D. at the direction of an Assistant Director of the Office of Distributions, OFM is authorized to pay the Fund Administrator’s fees and expenses from the Fair Fund . . . so long as the total amount paid to the Fund Administrator, including the invoice to be paid, does not exceed the total amount of the approved cost proposal submitted by the Fund Administrator."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
The Commission ordered that: "A. Epiq is appointed as the Fund Administrator . . . B. Epiq shall obtain a bond . . . in the amount of $15,000,000.00; C. the Fund Administrator will submit invoices to the Commission staff for services rendered . . . and D. at the direction of an Assistant Director of the Office of Distributions, OFM is authorized to pay the Fund Administrator’s fees and expenses from the Fair Fund . . . so long as the total amount paid to the Fund Administrator, including the invoice to be paid, does not exceed the total amount of the approved cost proposal submitted by the Fund Administrator."
Fair Funds
Monetary Penalties:
Civil Penalty
Individual:
$15,000,000.00
Shared:
Related Documents:
33-11326
12-Nov-2024
Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On November 12, 2024, the SEC instituted settled cease-and-desist proceedings against Elanco Animal Health Inc., stating: "This matter concerns Elanco’s failure to disclose material information concerning its
sales practices that rendered statements it made about its revenue growth misleading."
SEC Charges Indiana-Based Animal Health Products Company with Antifraud Violations
On November 12, 2024, the SEC "announced antifraud charges against Elanco Animal Health Inc. for
misleading investors when it made statements about its revenue growth
and end-user demand without also disclosing its reliance on certain
quarter-end sales incentives that were necessary to achieve that revenue
and caused its distributors to purchase goods in excess of existing end
user demand. Elanco has agreed to pay $15 million to settle the charges."
34-102292
27-Jan-2025
Administrative Proceeding
Extension Order
The Commission ordered that: "the Division’s request for an extension of time until January 21, 2026, to submit a Proposed Plan of Distribution is granted."
34-102489
26-Feb-2025
Administrative Proceeding
Order Appointing Tax Administrator
The Commission ordered that: "Heffler, Radetich & Saitta, LLP is appointed as the Tax Administrator for the QSF in the above-referenced proceeding."
34-104419
17-Dec-2025
Administrative Proceeding
Second Extension Order
The Commission ordered that: "the Division’s request for an extension of time until March 20, 2026, to submit a Proposed Plan of Distribution is granted."
34-104992
13-Mar-2026
Administrative Proceeding
Notice of Proposed Plan of Distribution and Opportunity for Comment
The Commission stated: "Notice is hereby given . . . that the Division of Enforcement has submitted to the Commission a proposed plan of distribution (the “Proposed Plan”) for the distribution of monies paid in the above-captioned matter."
Proposed Plan of Distribution
The Commission stated: "The Division of Enforcement submits this Proposed Plan of Distribution (the “Plan”) to the United States Securities and Exchange Commission (the “Commission”) . . . This Plan provides for the distribution of a Fair Fund (the “Fair Fund”), comprised of civil money penalties collected from Elanco Animal Health Inc. (“Elanco” or the “Respondent”) in the above-captioned matter. . . . the Plan seeks to compensate investors who were harmed by the Respondent’s conduct described in the Order, in connection with Elanco’s failure to disclose material information concerning its sales practices that rendered statements it made about its revenue growth misleading."
